process control system (pcs) pi & high...
TRANSCRIPT
© Copyr i gh t 2014 O SIs o f t , LLC .
Presented by
Process Control
System (PCS) ,
PI System 2012 &
High Availability
Myles Sumlin: Genentech
F. Lewis Cain: Control Systems Integration
© Copyr i gh t 2014 O SIs o f t , LLC .
Roche At a Glance
• Founded 1896 in Basel, Switzerland
• Founding families still hold majority stake
• Employing 85,000 people
• Currently active in 150 countries on all continents
• Sales 2013: 46.8 billion Swiss Francs
• Leadership in pharmaceuticals (#4)*
• World’s largest biotech company (position #1)* with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS
• Leadership in in vitro diagnostics (#1) and pioneer in diabetes management
• Unique innovation model
2
* Source: Decision Resources, Q3/2013
© Copyr i gh t 2014 O SIs o f t , LLC .
Manufacturing and Procurement
3
26 Manufacturing Sites:17 Pharmaceuticals | 7 Diagnostics | 2 joint sites
Employees:17,137
Portfolio:Over 100 medicines | 4,000 tests | 196 instruments
© Copyr i gh t 2014 O SIs o f t , LLC .
• Patients… Science… People
Science is Personal• At Genentech, we're passionate about finding solutions for people
facing the world's most difficult-to-treat conditions. That's why we use
cutting-edge science to create and deliver innovative medicines
around the globe.
4
We commit ourselves to high standards of
integrity in contributing to the best
interests of patients, the medical
profession, our employees and our
communities based on the continual
pursuit of scientific excellence.
© Copyr i gh t 2014 O SIs o f t , LLC .
• Over 20 Key Actively Marketed Products
Genentech Key Actively Marketed
Products
5
Genentech actively markets approximately 35 products or devices, including products which were previously marketed
as Roche products that are now being marketed by Genentech in the United States. Tamilfu is currently marketed
under the Roche brand in the U.S.
In 1998 Genentech licensed U.S. marketing and development rights to interferon gamma, including Actimmune, to Connetics Corporation. Thereafter, Connetics sublicensed,
then later assigned, all of its rights to InterMune Pharmaceuticals, Inc.
In 2002 Protropin manufacturing was discontinued.
In June 2004 Nutropin Depot commercialization was discontinued.
In April 2009 Genentech announced a phased voluntary withdrawal of the psoriasis drug Raptiva from the U.S. market.
In April 2012 Boniva commercialization was discontinued.
© Copyr i gh t 2014 O SIs o f t , LLC .
Agenda
• Business Challenge
• Project
• Solution
• Results and Benefits
• Questions
6
© Copyr i gh t 2014 O SIs o f t , LLC .
Business Challenge
• Batch Loss in 2010
• Redundancy?
• Barriers:
– Cost
– Technology
• Site Future State (Multi-product, Flexible)
7
© Copyr i gh t 2014 O SIs o f t , LLC .
DeltaV Upgrade Project (2013)
• Redundancy theme
• DeltaV 11.3 – support for Enterprise PI System
• OSIsoft PI High Availability (PI HA)
• Less Cost constraints
8
© Copyr i gh t 2014 O SIs o f t , LLC .
DeltaV Upgrade Project (2013)
• PI System requirements
– Redundancy
– No PI Batch
– Control Cost
– Expandable
9
© Copyr i gh t 2014 O SIs o f t , LLC .
Solution
• DeltaV 11.3 Enterprise PI
• Virtual Machines with HP
Blade servers as hosts
• PI Server 2012
• OSIsoft Smart Connector
Interface
• Redundancy at each level
10
© Copyr i gh t 2014 O SIs o f t , LLC .
Solution - ArchitectureDeltaV Application Station
(OPC DA)
PI Server
Collective (Svr 1)
PI AF Server
(SQL Svr 1)PI AF Server
(SQL Svr 2)
PI Server
Collective (Svr 2)
OSIsoft
Smart
Connector
Interface
DeltaV Application Station
2 (OPC DA)OSIsoft
Smart
Connector
Interface
11
© Copyr i gh t 2014 O SIs o f t , LLC .
Solution - Integration
• Integration with “Plant PI” System
– PI to PI Interface
– PI Auto Point Synchronization
– PI Notifications
– PI WebParts
12
© Copyr i gh t 2014 O SIs o f t , LLC .
Results and Benefits
• Reliable System
– Eliminated existing errors and system can be
upgraded aside from DeltaV System
• Product Quality
– Redundancy at each level
• Leverage Plant PI System
– System monitoring, Data Analysis
13
© Copyr i gh t 2014 O SIs o f t , LLC .
Future Initiatives
• PI Coresight expansion (2014)
• PI Event Frames migration (2014)
• PI Advanced Computing Engine (PI ACE) /
PI Asset Based Analytics configuration (TBD)
• Expand PI Notifications user base (TBD)
• SharePoint 2013 upgrade
14
© Copyr i gh t 2014 O SIs o f t , LLC .
• Reliable system
• Product Quality
• Leverage Plant PI System
Solution Results and Benefits
PCS High Availability
Business Challenge
• Legacy PI (DeltaV)
• No redundancy (batch loss)
• Not prepared for site
expansion activities
• PI Server 2012, PI HA
• Virtual Machines
• Redundant PI Interfaces on
DeltaV Application nodes
• PI to PI Interface
Unique solution that provide PI System redundancy while
providing a robust architecture that will meet future
expansion activities.
15
© Copyr i gh t 2014 O SIs o f t , LLC .
Special Thanks
• OSIsoft: Troy Carbaugh, Ryan Frijas
• Control Systems Integration: Lewis Cain
• Emerson Process Management: Darwin
Marcelino, Triciamae Par, Wilma Ocampo,
Ferdinand Sanchez
16
© Copyr i gh t 2014 O SIs o f t , LLC .
Questions
17
© Copyr i gh t 2014 O SIs o f t , LLC .
Contact Info
• Automation Engineer
• Genentech, Inc
• Managing Director
• Control Systems Integration, Inc
18
© Copyr i gh t 2014 O SIs o f t , LLC .
Brought to you by